middle.news
EMVision Raises $2M in Oversubscribed Share Plan, Boosting $14M Total for Trials
11:02am on Friday 31st of October, 2025 AEDT
•
Healthcare
Read Story
EMVision Raises $2M in Oversubscribed Share Plan, Boosting $14M Total for Trials
11:02am on Friday 31st of October, 2025 AEDT
Key Points
Oversubscribed Share Purchase Plan raised $2 million
Total capital raised reaches $14 million including recent $12 million placement
Funds to support pivotal clinical trials and FDA submission for emu device
Share allocations scaled back to ensure equitable distribution
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Emvision Medical Devices (ASX:EMV)
OPEN ARTICLE